U.S. markets closed

Insmed Incorporated (INSM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
38.92+0.79 (+2.07%)
At close: 4:00PM EST

38.92 0.00 (0.00%)
After hours: 5:22PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close38.13
Open38.20
Bid39.06 x 800
Ask40.00 x 1300
Day's Range37.96 - 39.48
52 Week Range12.09 - 45.44
Volume1,362,184
Avg. Volume882,671
Market Cap4.01B
Beta (5Y Monthly)2.29
PE Ratio (TTM)N/A
EPS (TTM)-3.01
Earnings DateApr 28, 2021 - May 03, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est53.56
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    PR Newswire

    Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to seven new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed's Compensation Committee and made as a material inducement to each employee's entry into employment with the Company.

  • Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
    PR Newswire

    Insmed Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

    Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the fourth quarter and full year ended December 31, 2020 and provided a business update.

  • ACCESSWIRE

    Insmed, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / February 25, 2021 / Insmed, Inc. (NASDAQ:INSM) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 25, 2021 at 8:30 AM Eastern Time.